NuCana PLC (NCNA)
1.27
-0.01
(-0.78%)
USD |
NASDAQ |
Nov 21, 16:00
1.28
+0.01
(+0.79%)
After-Hours: 20:00
NuCana Enterprise Value: -11.87M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -11.87M |
| November 20, 2024 | -11.85M |
| November 19, 2024 | -11.73M |
| November 18, 2024 | -11.49M |
| November 15, 2024 | -11.37M |
| November 14, 2024 | -11.24M |
| November 13, 2024 | -11.17M |
| November 12, 2024 | -11.13M |
| November 11, 2024 | -11.22M |
| November 08, 2024 | -11.34M |
| November 07, 2024 | -11.35M |
| November 06, 2024 | -11.31M |
| November 05, 2024 | -11.28M |
| November 04, 2024 | -11.24M |
| November 01, 2024 | -11.26M |
| October 31, 2024 | -11.08M |
| October 30, 2024 | -10.83M |
| October 29, 2024 | -10.79M |
| October 28, 2024 | -10.77M |
| October 25, 2024 | -10.70M |
| October 24, 2024 | -10.61M |
| October 23, 2024 | -10.62M |
| October 22, 2024 | -10.57M |
| October 21, 2024 | -10.54M |
| October 18, 2024 | -10.50M |
| Date | Value |
|---|---|
| October 17, 2024 | -10.34M |
| October 16, 2024 | -10.57M |
| October 15, 2024 | -10.50M |
| October 14, 2024 | -10.39M |
| October 11, 2024 | -9.914M |
| October 10, 2024 | -9.869M |
| October 09, 2024 | -9.846M |
| October 08, 2024 | -9.891M |
| October 07, 2024 | -10.41M |
| October 04, 2024 | -10.27M |
| October 03, 2024 | -10.30M |
| October 02, 2024 | -10.18M |
| October 01, 2024 | -10.09M |
| September 30, 2024 | -9.554M |
| September 27, 2024 | -9.217M |
| September 26, 2024 | -8.543M |
| September 25, 2024 | -7.870M |
| September 24, 2024 | -7.240M |
| September 23, 2024 | -7.465M |
| September 20, 2024 | -7.499M |
| September 19, 2024 | -7.398M |
| September 18, 2024 | -6.993M |
| September 17, 2024 | -6.409M |
| September 16, 2024 | -0.4114M |
| September 13, 2024 | -9.015M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-42.87M
Minimum
Mar 08 2022
239.17M
Maximum
Jan 15 2021
43.46M
Average
18.11M
Median
Enterprise Value Benchmarks
| Adaptimmune Therapeutics PLC | 26.67M |
| Biodexa Pharmaceuticals PLC | -3.355M |
| Autolus Therapeutics PLC | 98.72M |
| Mereo BioPharma Group PLC | 495.96M |
| Bicycle Therapeutics PLC | 508.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.826M |
| Total Expenses (Quarterly) | 10.44M |
| EPS Diluted (Quarterly) | -3.785 |
| Earnings Yield | -1.31K% |